Comments to FDA: Warning for OTC Acetaminophen-Containing Drug Products and Serious Skin Reactions

Docket Number:

FDA–2014–D–1862

CHPA appreciates the opportunity to provide comments to the FDA in response to the draft guidance for industry “Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions”.